Market Cap

Energenesis Biomedical CO.,LTD. Market Capitalization:

TW$4.65 Billion

TWD as of July 1, 2023

US$149.3 Million

business Energenesis Biomedical CO.,LTD. Company Profile

Energenesis Biomedical CO.,LTD. Main Stock Listing

TWSE: 6657

Market Capitalization History of Energenesis Biomedical CO.,LTD.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Energenesis Biomedical CO.,LTD. market cap

Date Market Cap YoY Change
Jan. 1, 2023 TW$3.22 B 16.25%
Jan. 1, 2022 TW$2.77 B -6.33%
Jan. 1, 2021 TW$2.96 B -42.08%
Jan. 1, 2020 TW$5.11 B 47.65%
Jan. 1, 2019 TW$3.46 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Energenesis Biomedical CO.,LTD. Categories

Taiwan languages Healthcare languages Biotechnology
Taiwan Healthcare Taiwan Biotechnology

Stocks & Indices

Energenesis Biomedical CO.,LTD. has the following listings and related stock indices.


Stock: TWSE: 6657

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.